Interesting Stocks

[BlueWolf]

Looks like IONQ is acquiring SKYT. Should be good for both companies.

[BlueWolf]

Here’s an another interesting company, Fauna Robotics, making humanoid robots. They just got gobbled up by Amazon.

[BlueWolf]

Came across another fascinating stock this week, COMPASS Pathways (CMPS). This one is a super speculator. They’re pre revenue, but they’re developing psilocybin therapy for treatment-resistant depression. Shades of Timothy Leary. I’m gonna have to keep an eye on this one just to see what happens here. I’m not saying this is an investment opportunity yet, but it’ll be fun to follow.

[jiesen]

The chart for CMPS is impressive, in that it went from under $4 to over $10 in a year. But the numbers on their books don't make any sense to me... They spend $100M+ every year (half on Sales/admin), but have 0 revenues. Maybe they're just getting started, but with no sales numbers to look at, I don't know if $10/shr is good or bad. Are they selling the therapy, or just selling stock?

[jiesen]

...it'll be fun to follow.

yep, it's a curious one, and I'm interested to see how it plays out, too.

[BlueWolf]

The chart for CMPS is impressive, in that it went from under $4 to over $10 in a year. But the numbers on their books don't make any sense to me... They spend $100M+ every year (half on Sales/admin), but have 0 revenues. Maybe they're just getting started, but with no sales numbers to look at, I don't know if $10/shr is good or bad. Are they selling the therapy, or just selling stock?

They’re pre-revenue. They are working on getting FDA approval for their treatment.

[jiesen]

Yeah, that's what I figured. Question is, can they make back a half-billion in R&D costs by selling therapy treatments? Without seeing what the market is willing to pay for this stuff, it's hard to justify a $4 share price, let alone $14. Maybe it works out, or approval gives this stock a quick bump up and a chance to get out with a few bucks in profit, but I think it's looking like a long shot to become a viable ongoing business (as most pre-approval drug companies are).

[jiesen]

Excellent! I’ve been watching QBTS closely. I saw it soaring last week. All quantum stocks soared last week including another I’m watching, IONQ.

QBTS was setup with a really nice pattern for entry around the 12th, but I didn’t pull the trigger. I don’t know why because I like the stock and I think it has big long term potential. Glad you got in at a good point, though. I’d definitely hold that one.

QBTS, IONQ, SKYT all made nice moves this week - hope you're still in one/some of these quantum plays - US gov't is now on board and supporting this tech, so a healthy investment in these is starting to really pay off!

[jiesen]

My only remaining position in these now is in QBTS (and perhaps MSFT, if you count that as a quantum play). I had some SKYT as well but sold it at 34, thinking 35 was the max it would trade at, due to the $35 acquisition price.... of course part of the purchase was in IONQ, so there is upside still with SKYT. I want to hold QBTS until the market starts talking trillions for some of these quantum chip companies (besides MSFT and GOOG). It could be my lottery ticket! Timeline should be ~3-5 years before we know which one(s) are the actual winner(s) in the race to own the Google/ChatGPT of quantum tech application. It's a fact that they're just getting started with this tech, and it will be HUGE very soon. My guess is the winner(s) gets bought by either MSFT, GOOG, or xAI for upwards of $500B in cash and stock.

[BlueWolf]

Yes, I’m still holding my quantum positions. My biggest disappointment has been MSFT, which has problems not related to their quantum tech. It’s really hard to tell which one of the big four (IONQ, QBTS, QUBT, RGTI) is going to be a big winner here. Right now, the tide is lifting all the boats. Then there’s probably going to be somebody we haven’t heard of yet too.